Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RISING-STAR: SGLT2 inhibitor plus insulin titration in type 1 diabetes
jRCTs051190114Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2020
- Countries
- 1
01
Overview
Randomised, open-label trial in diabetes mellitus type 1 (T1D) (2 arms), sponsored by AstraZeneca. Primary endpoint: Frequency of hypoglycemia per day by SMBG during intervention. Started Mar 2020; status: completed.
02
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on jRCTs051190114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190114.